Premature Rupture of Membrane — Magnesium Sulphate in Premature Rupture of Membranes
Citation(s)
ACOG Committee on Practice Bulletins-Obstetrics ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007 Apr;109(4):1007-19.
Crowther CA, Harding JE Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003935. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD003935.
Kaltreider DF, Kohl S Epidemiology of preterm delivery. Clin Obstet Gynecol. 1980 Mar;23(1):17-31. Review.
McNamara HC, Crowther CA, Brown J Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour. Cochrane Database Syst Rev. 2015 Dec 14;(12):CD011200. doi: 10.1002/14651858.CD011200.pub2. Review.
Parry S, Strauss JF 3rd Premature rupture of the fetal membranes. N Engl J Med. 1998 Mar 5;338(10):663-70. Review.
Weiner CP, Renk K, Klugman M The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol. 1988 Jul;159(1):216-22. Erratum in: Am J Obstet Gynecol 1991 Sep;165(3):785.
Magnesium Sulphate for Tocolysis in Preterm Prelabour Rupture of Membranes
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
